Endo Wins Dismissal Of FTC's Suit Over Impax Opioid Deal

By Khorri Atkinson · March 24, 2022, 3:40 PM EDT

Endo Pharmaceuticals on Thursday secured a D.C. federal court's dismissal of the Federal Trade Commission's antitrust suit accusing it of entering a second "pay-for-delay" agreement with Impax Laboratories to stave off...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. et al

Case Number

1:21-cv-00217

Court

District Of Columbia

Nature of Suit

Anti-Trust

Date Filed

January 25, 2021